Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
BACKGROUND: Bone mineral density (BMD) is influenced by multiple factors. Recent studies have highlighted a possible relationship between serotonin and BMD. Patients with neuroendocrine tumours (NETs) frequently have elevated urinary 5-hydroxy-indoleacetic acid (5-HIAA) levels, a serotonin metabolit...
Hauptverfasser: | , , , , , , |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2014
|
Search Result 1
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
Veröffentlicht 2014
Journal article